Lung function trajectories depend on age group in children with spinal muscular atrophy


  • Lung function decline is steeper in children with spinal muscular atrophy (SMA) type 2 between ages 5 and 12, while in SMA type 3 the decline is steepest after age 8.

Why this matters

    Respiratory function decline is the most common non-neurologic symptom in SMA and a known cause of mortality. Despite this, most studies have focused on treatments to improve motor function and life expectancy. This is the largest observational study on respiratory functions in pediatric SMA and provides novel information on which to base future treatments and clinical trials on.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.